title: Hip-Arg-Phe-, Hip-Phe-Arg- and Hip-His-Leu-cleaving dipeptidyl carboxypeptidases in human adrenal tumors.
abstract: Hip-Arg-Phe-, Hip-Phe-Arg- and Hip-His-Leu-cleaving dipeptidyl carboxypeptidase activities were measured in the supernatant (S2) and pellet (P2) fractions obtained by ultracentrifugation of human adrenal tumor preparations. Negligible enzyme activity was found in cortical tumor whereas highly significant activities were present in the P2 fractions of the two pheochromocytoma specimens. The hydrolysis rates, expressed in terms of the percent of added substrate were 58-66%/60 min for Hip-Phe-Arg, 55-58%/60 min for Hip-Arg-Phe and 19-30%/60 min for Hip-His-Leu. The angiotensin-converting enzyme inhibitor, captopril, differentially inhibited the enzyme splitting Hip-His-Leu versus the one cleaving Hip-Arg-Phe; Hip-Phe-Arg is probably the substrate of both. It is concluded that the Hip-Arg-Phe-cleaving enzyme in adrenomedullary tumor is probably identical to the purportedly novel dipeptidyl carboxypeptidase that we detected earlier in rabbit ear artery wall, which converts (Met5)-enkephalin-Arg6,Phe7 to (Met5)-enkephalin.
authors.affiliation: Department of Pharmacology, Semmelweis University of Medicine, Budapest, Hungary.
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rónai
authors.forename: J
authors.initials: J
authors.lastname: Lengyel
authors.forename: T
authors.initials: T
authors.lastname: Nagy
authors.forename: G
authors.initials: G
authors.lastname: Orosz
authors.forename: V
authors.initials: V
authors.lastname: Adlesz
authors.forename: K
authors.initials: K
authors.lastname: Racz
authors.forename: K
authors.initials: K
authors.lastname: Magyar
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000201:enzymology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000737:chemistry / Q000201:enzymology; D002216:Captopril / Q000494:pharmacology; D002268:Carboxypeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006626:Hippurates / Q000378:metabolism; D006801:Humans; D009479:Neuropeptides / Q000378:metabolism*; D010673:Pheochromocytoma / Q000201:enzymology*; D011817:Rabbits; D013379:Substrate Specificity
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D006626:Hippurates; D009479:Neuropeptides; D002216:Captopril; D002268:Carboxypeptidases; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; C030514:hippuric acid